Clinical Trial Update: A Study of TQ-A3334 Combined With Entecavir in the Treatment of Chronic Hepatitis B [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating TQ-A3334 in combination with entecavir for Chronic Hepatitis B.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• ENTECAVIR (ENTECAVIR)
• TQ-A3334 (TQ-A3334)

Snippet

Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Conditions: Chronic Hepatitis B | Phase 2 | Status: UNKNOWN